EVMN
Evommune, Inc.
9.70$
+3.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Evommune, Inc. (EVMN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -76 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| -30 | -58 | -76 | |
| 1.0 | 1.3 | 1.4 | |
| – | – | 5.9 | |
| 3.3 | 7.4 | -4.1 | |
| 0.1 | 0.1 | 0.2 | |
| -48 | -4.0 | -115 | |
| – | – | -0.4 | |
| 64 | 49 | 221 | |
| 29 | -13 | 28 | |
| -30 | -58 | -77 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.